Pfizer Inc, Andover, MA, USA.
Birck Nanotechnology Center, Purdue University, 1205 W State St., West Lafayette, IN, 47907, USA.
Pharm Res. 2023 Oct;40(10):2433-2455. doi: 10.1007/s11095-023-03607-9. Epub 2023 Oct 2.
The purpose of this paper is to re-visit the design of three steps in the freeze-drying process, namely freezing, primary drying, and secondary drying steps. Specifically, up-to-date recommendations for selecting freeze-drying conditions are provided based on the physical-chemical properties of formulations and engineering considerations.
This paper discusses the fundamental factors to consider when selecting freezing, primary drying, and secondary drying conditions, and offers mathematical models for predicting the duration of each segment and product temperature during primary drying. Three simple heat/mass transfer primary drying (PD) models were tested, and their ability to predict product temperature and sublimation time showed good agreement. The PD models were validated based on the experimental data and utilized to tabulate the primary drying conditions for common pharmaceutical formulations, including amorphous and partially crystalline products. Examples of calculated drying cycles, including all steps, for typical amorphous and crystalline formulations are provided.
The authors revisited advice from a seminal paper by Tang and Pikal (Pharm Res. 21(2):191-200, 2004) on selecting freeze-drying process conditions and found that the majority of recommendations are still applicable today. There have been a number of advancements, including methods to promote ice nucleation and computer modeling for all steps of freeze-drying process. The authors created a database for primary drying and provided examples of complete freeze-drying cycles design. The paper may supplement the knowledge of scientists and formulators and serve as a user-friendly tool for quickly estimating the design space.
本文旨在重新审视冻干过程的三个步骤(冷冻、初级干燥和次级干燥)的设计。具体而言,根据制剂的物理化学性质和工程考虑,提供了最新的选择冻干条件的建议。
本文讨论了选择冷冻、初级干燥和次级干燥条件时应考虑的基本因素,并提供了预测每个阶段持续时间和初级干燥过程中产品温度的数学模型。测试了三个简单的热/质量传递初级干燥(PD)模型,它们预测产品温度和升华时间的能力显示出良好的一致性。基于实验数据验证了 PD 模型,并利用其对常见药物制剂的初级干燥条件进行了列表,包括无定形和部分结晶产品。提供了典型无定形和结晶制剂计算干燥循环(包括所有步骤)的示例。
作者重新审视了 Tang 和 Pikal(Pharm Res. 21(2):191-200, 2004)关于选择冻干工艺条件的开创性论文中的建议,发现其中大多数建议在今天仍然适用。已经有了许多进展,包括促进冰核形成的方法和用于冻干过程所有步骤的计算机建模。作者创建了一个初级干燥数据库,并提供了完整冻干循环设计的示例。本文可以补充科学家和配方师的知识,并作为快速估计设计空间的用户友好工具。